Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

Journal of Internal Medicine - Tập 271 Số 2 - Trang 111-121 - 2012
Qi Tian1, Nathan D. Price1, Leroy Hood1
1From the Institute for Systems Biology, Seattle, WA, USA

Tóm tắt

Abstract.  Tian Q, Price ND, Hood L (Institute for Systems Biology, Seattle, WA, USA). Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine (Key Symposium). J Intern Med 2012; 271: 111–121.A grand challenge impeding optimal treatment outcomes for patients with cancer arises from the complex nature of the disease: the cellular heterogeneity, the myriad of dysfunctional molecular and genetic networks as results of genetic (somatic) and environmental perturbations. Systems biology, with its holistic approach to understanding fundamental principles in biology, and the empowering technologies in genomics, proteomics, single‐cell analysis, microfluidics and computational strategies, enables a comprehensive approach to medicine, which strives to unveil the pathogenic mechanisms of diseases, identify disease biomarkers and begin thinking about new strategies for drug target discovery. The integration of multidimensional high‐throughput ‘omics’ measurements from tumour tissues and corresponding blood specimens, together with new systems strategies for diagnostics, enables the identification of cancer biomarkers that will enable presymptomatic diagnosis, stratification of disease, assessment of disease progression, evaluation of patient response to therapy and the identification of reoccurrences. Whilst some aspects of systems medicine are being adopted in clinical oncology practice through companion molecular diagnostics for personalized therapy, the mounting influx of global quantitative data from both wellness and diseases is shaping up a transformational paradigm in medicine we termed ‘predictive’, ‘preventive’, ‘personalized’, and ‘participatory’ (P4) medicine, which requires new strategies, both scientific and organizational, to enable bringing this revolution in medicine to patients and to the healthcare system. P4 medicine will have a profound impact on society – transforming the healthcare system, turning around the ever escalating costs of healthcare, digitizing the practice of medicine and creating enormous economic opportunities for those organizations and nations that embrace this revolution.

Từ khóa


Tài liệu tham khảo

10.1038/nrclinonc.2010.227

Price ND, 2009, Genomic and Personalized Medicine: From Principles to Practice, 131

10.1126/science.1104635

10.1016/j.cell.2011.02.013

10.1158/0008-5472.CAN-04-3218

10.1056/NEJMct071828

10.1056/NEJMoa0810699

10.1056/NEJMoa0804385

10.1056/NEJMoa1014209

10.1126/science.1164382

10.1056/NEJMoa1005143

10.1038/nature07485

10.1056/NEJMoa0903840

10.1038/nature09837

10.1038/nature08658

10.1038/nature09004

10.1073/pnas.0607057103

10.1146/annurev-pathol-121808-102113

10.1038/nrc3063

10.1073/pnas.0806007105

10.1523/JNEUROSCI.4178-07.2008

10.1038/367645a0

10.1073/pnas.0530291100

Singh SK, 2003, Identification of a cancer stem cell in human brain tumors, Cancer Res, 63, 5821

10.1016/j.ccr.2011.01.039

10.1038/nature07385

10.1126/science.1186802

10.1016/j.cell.2011.03.007

10.1038/msb.2009.10

10.1073/pnas.0813371106

10.1002/cncr.22774

10.1200/JCO.2010.30.5151

10.1038/ng.128

10.1073/pnas.0904720106

10.1038/nature09744

10.1126/scitranslmed.3000702

10.1038/nature09807

10.1056/NEJMoa1002011

10.1056/NEJMoa1006448

10.1056/NEJMoa1002028

10.1038/nm.1890

10.1056/NEJMoa041588

10.1073/pnas.0611373104

10.1073/pnas.1018696108

10.1016/j.cell.2009.05.051

10.1073/pnas.1013699108

10.1073/pnas.1009320107

HoodL.Biological Complexity Under Attack A Personal View of Systems Biology and the Coming of “Big” Science.Genetic Engineering & Biotechnology News 2011.